PAXLOVID, a new antiviral pill to treat Covid-19, will be rolled out at selected polyclinics and Public Health Preparedness Clinics (PHPCs) in phases to patients to reduce the likelihood of hospitalisation.
This is the first Covid pill approved by the Health Sciences Authority (HSA) for use here. Currently, treatment is based on symptoms such as cough, fever and sore throat.
Already a subscriber? Log in
Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.
Cancel anytime. Ad-free. Unlimited access with perks.
